prednisone has been researched along with ixazomib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, X; Yue, D | 1 |
| Bao, S; Chai, G; Chen, X; Liu, C; Mao, J; Zhi, Y; Zhu, J | 1 |
1 review(s) available for prednisone and ixazomib
| Article | Year |
|---|---|
Efficacy of maintenance treatment in patients with multiple myeloma: a systematic review and network meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Boron Compounds; Bortezomib; Glycine; Humans; Lenalidomide; Multiple Myeloma; Network Meta-Analysis; Prednisone; Thalidomide | 2022 |
1 other study(ies) available for prednisone and ixazomib
| Article | Year |
|---|---|
Ixazomib promotes CHOP-dependent DR5 induction and apoptosis in colorectal cancer cells.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Boron Compounds; Cell Line, Tumor; Colorectal Neoplasms; Cyclophosphamide; Doxorubicin; Glycine; Humans; Prednisone; Receptors, TNF-Related Apoptosis-Inducing Ligand; Transfection; Vincristine | 2019 |